Tag: Clinical trials
Global webcast: what we are learning from clinical trials
How all trials, successful or not, inform future research
2022 McDonald Fellowships and Du Pré Grant recipients announced
MSIF is proud to announce the recipients of the 2022 McDonald Fellowships and Du Pré Grants, from Mongolia, Brazil, Argentina and India.
Key topics in MS research
Thousands of scientists are undertaking research into all aspects of MS, furthering our understanding of the disease and how to prevent, treat and manage it.
Researchers strengthen the link between Epstein-Barr Virus (EBV) and the risk of developing MS
Does EBV cause MS?
What treatments are approved for children and young people with MS?
We look into these in more detail to understand how the treatment decisions are made by regulators.
2021 McDonald Fellowships and Du Pré Grant recipients announced
MSIF is proud to announce the recipients of the 2021 McDonald Fellowships and Du Pré Grants, from Argentina, Brazil, Egypt, Iran, and Tunisia
Winner of the 2021 Young Investigator Award
Dr Giacomo Boffa receives the 2021 Young Investigator Award on his project on using aHSCT in individuals with secondary progressive MS
Clinical research and trials
Research and clinical trials are taking place around the world, trying to find and improve treatments for MS
2020 McDonald Fellowships and Du Pré Grant recipients announced
MSIF is proud to announce the recipients of the 2020 McDonald Fellowships and Du Pré Grants, from Iran, Zambia, Brazil, Turkey, and Argentina
Winner of the 2020 Young Investigator Award
Helen Onuorah receives the 2020 Young Investigator Award on her project "Racial inequalities in MS research participation"
Clinical trials in children and adolescents – an updated global consensus
The International Pediatric MS Study Group (IPMSSG) have updated recommendations for standards in pediatric clinical trials.
Non-processed red meat linked with reduced risk of MS
New research on the relationship between processed and non-processed red meat consumption and the risk of developing MS